+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

NovoEight Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6104051
The novoeight market research report is one of a series of new reports that provides novoeight market statistics, including novoeight industry global market size, regional shares, competitors with a novoeight market share, detailed novoeight market segments, market trends and opportunities, and any further data you may need to thrive in the novoeight industry. This novoeight market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growth in the forecast period can be attributed to rising patient awareness, increasing use of prophylactic treatment, home treatment and self-administration growth, expansion of hemophilia treatment centers, and growing government investments. Major trends in the forecast period include patient-centered innovation, innovations in biotechnology, integration of telemedicine, advanced treatment centers, and integration with electronic health records (EHRs)

The increasing prevalence of hemophilia is expected to drive the growth of the NovoEight market. Hemophilia is a genetic disorder where the blood fails to clot properly, leading to excessive bleeding even from minor injuries. The growing prevalence of hemophilia is largely due to advancements in diagnostic methods, increased awareness, and better reporting systems, resulting in more individuals being diagnosed with the condition. NovoEight helps individuals with hemophilia by effectively managing and preventing bleeding episodes, improving clotting function, and reducing the risk of spontaneous bleeding, which in turn enhances mobility and quality of life. For example, according to the World Federation of Hemophilia, 427,685 individuals worldwide were diagnosed with bleeding disorders in 2022, including 257,146 cases of hemophilia. As a result, the rising prevalence of hemophilia is driving market growth for NovoEight.

The growing demand for personalized medicine is also contributing to the growth of the NovoEight market. Personalized medicine tailors treatments to individual patients based on their genetic, environmental, and lifestyle factors. This shift is being fueled by advances in genetic research, greater awareness of personalized treatments, and a desire for more targeted therapies that minimize side effects while improving patient outcomes. NovoEight, a recombinant factor VIII therapy, fits within this trend by offering customized treatment options for patients with hemophilia A. Healthcare providers can adjust dosing regimens based on individual patient needs, genetic makeup, and therapy responses, thereby improving outcomes and overall quality of life. For instance, the Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized therapies for rare diseases, up from six in 2022. This increasing demand for personalized medicine is fueling the growth of the NovoEight market.

The rising healthcare expenditure is also expected to propel the growth of the NovoEight market. Healthcare expenditure encompasses the total resources spent on healthcare services and goods in a specific region or globally. Factors contributing to the rise in healthcare spending include aging populations, advancements in medical technologies, increased prevalence of chronic diseases, higher patient expectations, and inflation in healthcare costs. NovoEight, a recombinant factor VIII therapy, contributes to reducing healthcare expenditure by lowering the frequency of bleeding episodes and reducing the need for emergency interventions. This leads to better long-term management of hemophilia A, decreases overall treatment costs, and improves patients' quality of life. According to a December 2023 report by the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion. Therefore, increasing healthcare expenditure is supporting the growth of the NovoEight market.

The key company operating in the novoeight market is Novo Nordisk A/S.

North America was the largest region in the novoeight market in 2024. The regions covered in novoeight report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the novoeight market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

NovoEight refers to turoctocog alfa, a recombinant coagulation factor VIII used to treat and prevent bleeding in individuals with hemophilia A, a genetic disorder characterized by a deficiency of factor VIII, an essential blood-clotting protein.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main indications for novoeight include hemophilia A and surgical procedures. Hemophilia A is a genetic disorder in which blood does not clot properly due to a lack of clotting factor VIII. NovoEight is distributed through hospital pharmacies, retail pharmacies, online pharmacies, and direct sales, and is used by a variety of end users, including pediatric and geriatric patients, as well as in hospitals, clinics, and homecare settings.

The novoeight market consists of sales of novoeight (recombinant factor VIII), novoseven (recombinant factor VII), novoeight [RFVIII] - lyophilized powder, and novoeight [RFVIII] prefilled syringe. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. NovoEight Market Characteristics
3. NovoEight Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. NovoEight Market Trends And Strategies5. NovoEight Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global NovoEight Growth Analysis And Strategic Analysis Framework
6.1. Global NovoEight PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global NovoEight Market Growth Rate Analysis
6.4. Global NovoEight Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global NovoEight Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global NovoEight Total Addressable Market (TAM)
7. Global NovoEight Pricing Analysis & Forecasts
8. NovoEight Market Segmentation
8.1. Global NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hemophilia A
  • Surgical Procedures
8.2. Global NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Direct Sales
8.3. Global NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Adult
  • Pediatric
  • Geriatric
  • Hospitals Or Clinics
  • Homecare Settings
9. Global NovoEight Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. NovoEight Market Regional And Country Analysis
10.1. Global NovoEight Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global NovoEight Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific NovoEight Market
11.1. Asia-Pacific NovoEight Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China NovoEight Market
12.1. China NovoEight Market Overview
12.2. China NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India NovoEight Market
13.1. India NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan NovoEight Market
14.1. Japan NovoEight Market Overview
14.2. Japan NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia NovoEight Market
15.1. Australia NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea NovoEight Market
16.1. South Korea NovoEight Market Overview
16.2. South Korea NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe NovoEight Market
17.1. Western Europe NovoEight Market Overview
17.2. Western Europe NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK NovoEight Market
18.1. UK NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany NovoEight Market
19.1. Germany NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France NovoEight Market
20.1. France NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe NovoEight Market
21.1. Eastern Europe NovoEight Market Overview
21.2. Eastern Europe NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America NovoEight Market
22.1. North America NovoEight Market Overview
22.2. North America NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA NovoEight Market
23.1. USA NovoEight Market Overview
23.2. USA NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada NovoEight Market
24.1. Canada NovoEight Market Overview
24.2. Canada NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America NovoEight Market
25.1. South America NovoEight Market Overview
25.2. South America NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East NovoEight Market
26.1. Middle East NovoEight Market Overview
26.2. Middle East NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa NovoEight Market
27.1. Africa NovoEight Market Overview
27.2. Africa NovoEight Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa NovoEight Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa NovoEight Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. NovoEight Market Competitive Landscape And Company Profiles
28.1. NovoEight Market Competitive Landscape
28.2. NovoEight Market Company Profiles
28.2.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
29. Global NovoEight Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global NovoEight Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The NovoEight Market32. Recent Developments In The NovoEight Market
33. NovoEight Market High Potential Countries, Segments and Strategies
33.1 NovoEight Market In 2029 - Countries Offering Most New Opportunities
33.2 NovoEight Market In 2029 - Segments Offering Most New Opportunities
33.3 NovoEight Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

NovoEight Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on novoeight market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for novoeight ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The novoeight market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Indication: Hemophilia A; Surgical Procedures
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales
3) By End User: Adult; Pediatric; Geriatric; Hospitals Or Clinics; Homecare Settings

Key Companies Profiled: Novo Nordisk A/S

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Novo Nordisk A/S